Article
Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.
Pharmacogenomics - 1 Nov 2013
ten Brink Marloes H, van Bavel Tom, Swen Jesse J, van der Straaten Tahar, Bredius Robbert G M, Lankester Arjan C, Zwaveling Juliëtte, Guchelaar Henk-Jan
Abstract excerpt
BACKGROUND: Busulfan is used in preparative regimens prior to stem cell transplantation in pediatric patients. There is significant interpatient variability in busulfan pharmacokinetics (PK) and exposure is related to outcome. To date, only polymorphisms in genes encoding for glutathione-S-transferases were studied, but could only explain a small portion of the variability in PK. AIM: To investigate the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
